Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hodges Dwinal A"'
Autor:
Ghilardi, G., Chong, E.A., Svoboda, J., Wohlfarth, P., Nasta, S.D., Williamson, S., Landsburg, J.D., Gerson, J.N., Barta, S.K., Pajarillo, R., Myers, J., Chen, A.I., Schachter, L., Yelton, R., Ballard, H.J., Hodges Dwinal, A., Gier, S., Victoriano, D., Weber, E., Napier, E., Garfall, A., Porter, D.L., Jäger, U., Maziarz, R.T., Ruella, M., Schuster, S.J.
Publikováno v:
In Annals of Oncology September 2022 33(9):916-928
Autor:
Gauthier, Jordan *, Gazeau, Nicolas, Hirayama, Alexandre V., Hill, Joshua A., Wu, Vicky, Cearley, Aisling, Perkins, Paula, Kirk, Angela, Shadman, Mazyar, Chow, Victor A., Gopal, Ajay K., Hodges Dwinal, Alexandria, Williamson, Staci, Myers, Jessie, Chen, Andy, Nagle, Sarah, Hayes-Lattin, Brandon, Schachter, Levanto, Maloney, David G., Turtle, Cameron J., Sorror, Mohamed L., Maziarz, Richard T.
Publikováno v:
In Blood 30 June 2022 139(26):3722-3731
Autor:
Jordan Gauthier, Nicolas Gazeau, Alexandre V. Hirayama, Joshua A. Hill, Vicky Wu, Aisling Cearley, Paula Perkins, Angela Kirk, Mazyar Shadman, Victor A. Chow, Ajay K. Gopal, Alexandria Hodges Dwinal, Staci Williamson, Jessie Myers, Andy Chen, Sarah Nagle, Brandon Hayes-Lattin, Levanto Schachter, David G. Maloney, Cameron J. Turtle, Mohamed L. Sorror, Richard T. Maziarz
Publikováno v:
Blood
CD19-targeted chimeric antigen receptor-engineered (CD19 CAR) T cells are novel therapies showing great promise for patients with relapsed or refractory (R/R) aggressive B-cell non-Hodgkin lymphoma (B-NHL). Single-arm studies showed significant varia
Autor:
G. Ghilardi, E.A. Chong, J. Svoboda, P. Wohlfarth, S.D. Nasta, S. Williamson, J.D. Landsburg, J.N. Gerson, S.K. Barta, R. Pajarillo, J. Myers, A.I. Chen, L. Schachter, R. Yelton, H.J. Ballard, A. Hodges Dwinal, S. Gier, D. Victoriano, E. Weber, E. Napier, A. Garfall, D.L. Porter, U. Jäger, R.T. Maziarz, M. Ruella, S.J. Schuster
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 33(9)
Anti-CD19 chimeric antigen receptor T-cell immunotherapy (CAR-T) is now a standard treatment of relapsed or refractory B-cell non-Hodgkin lymphomas; however, a significant portion of patients do not respond to CAR-T and/or experience toxicities. Lymp
Autor:
Rachel Cook, Staci Williamson, Jessie Myers, Laura F. Newell, Jennifer N Saultz, Jessica T. Leonard, Brandon Hayes-Lattin, Arpita Gandhi, Levanto Schachter, Andy I. Chen, Jennifer Smith, Mariana Perez Varona Bolanos, Alexandria Hodges Dwinal, Robert Ahrenkiel, LeeAnn Farestrand, Chi Phan, Richard T Maziarz
Publikováno v:
Transplantation and Cellular Therapy. 28:S326-S327
Autor:
Nicolas Gazeau, Pere Barba, Gloria Iacoboni, Mi Kwon, Rebeca Bailen, Juan Luis Reguera, Lucía López-Corral, Rafael Hernani, Valentin Ortiz-Maldonado, Antonio Pérez-Martínez, Richard T Maziarz, Staci Williamson, Jessie Myers, Alexandria Hodges Dwinal, Eneida R. Nemecek, Mazyar Shadman, Andrew J. Cowan, Damian J. Green, Victor A. Chow, Alexandre V. Hirayama, David G. Maloney, Cameron J. Turtle, Jordan Gauthier
Publikováno v:
Transplantation and Cellular Therapy. 28:S185-S186